Second trimester anti-angiogenic proteins and preeclampsia

Pregnancy Hypertension

Volumn 2, Issue 2, 2012, Pages 158-163

  Haggerty, Catherine L ^a   Seifert, Michael E ^b   Tang, Gong ^a   Olsen, Jørn ^c,d   Bass, Debra C ^a   Ananth Karumanchi, S ^e   Ness, Roberta B ^f  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF AARHUS   (Denmark)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Preeclampsia; Soluble endoglin; Soluble fms like tryosine kinase 1

Indexed keywords

ENDOGLIN; PROTEIN TYROSINE KINASE; SOLUBLE ENDOGLIN; SOLUBLE FMS LIKE TYROSINE KINASE 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE REGISTRY; FEMALE; GESTATIONAL AGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MATERNAL AGE; PREECLAMPSIA; PRIMIPARA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT; SMOKING;

EID: 84859160142     PISSN: 22107789     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.preghy.2012.01.005     Document Type: Article

References (34)

1. K.Y. Lain, and J.M. Roberts Contemporary concepts of the pathogenesis and management of preeclampsia JAMA 287 2002 3183 3186 (Pubitemid 34686089)
2. R.B. Ness, and J.M. Roberts Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications Am J Obstet Gynecol 175 1996 1365 1370 (Pubitemid 26399006)
3. J.M. Roberts, K.Y. Lain, J.M. Roberts, and K.Y. Lain Recent Insights into the pathogenesis of pre-eclampsia Placenta 23 2002 359 372 (Pubitemid 41110499)
4. R.J. Levine, S.E. Maynard, C. Qian, K.H. Lim, L.J. England, and K.F. Yu Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683 (Pubitemid 38364626)
5. S. Helske, P. Vuorela, O. Carpen, C. Hornig, H. Weich, and E. Halmesmaki Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies Mol Hum Reprod 7 2001 205 210 (Pubitemid 32148349)
6. V. Tsatsaris, F. Goffin, C. Munaut, J.F. Brichant, M.R. Pignon, and A. Noel Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences J Clin Endocrinol Metabol 88 2003 5555 5563 (Pubitemid 37452769)
7. S.E. Maynard, J.Y. Min, J. Merchan, K.H. Lim, J. Li, and S. Mondal Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658 (Pubitemid 36278583)
8. H. Stepan, A. Unversucht, N. Wessel, R. Faber, H. Stepan, and A. Unversucht Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion Hypertension 49 2007 818 824 (Pubitemid 351664216)
9. A.C. Staff, K. Braekke, N.K. Harsem, T. Lyberg, M.R. Holthe, and A.C. Staff Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia Eur J Obstet Gynecol Reprod Biol 122 2005 33 39 (Pubitemid 41265677)
10. T. Chaiworapongsa, R. Romero, J. Espinoza, E. Bujold, K.Y. Mee, and L.F. Goncalves Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award Am J Obstet Gynecol 190 2004 1541 1547
11. R.J. Levine, C. Lam, C. Qian, K.F. Yu, S.E. Maynard, and B.P. Sachs Soluble endoglin and other circulating antiangiogenic factors in preeclampsia N Engl J Med 355 2006 992 1005 (Pubitemid 44343543)
12. R. Romero, J.K. Nien, J. Espinoza, D. Todem, W. Fu, and H. Chung A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate J Matern Fetal Neonat Med 21 2008 9 23
13. G.C. McKeeman, J.E. Ardill, C.M. Caldwell, A.J. Hunter, N. McClure, and G.C. McKeeman Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop Am J Obstet Gynecol 191 2004 1240 1246 (Pubitemid 39421577)
14. J. Olsen, M. Melbye, S.F. Olsen, T.I. Sorensen, P. Aaby, and A.M. Andersen The Danish National Birth Cohort - its background, structure and aim Scand J Pub Health 29 2001 300 307 (Pubitemid 33731020)
15. A.K. Klemmensen, S.F. Olsen, M.L. Osterdal, A. Tabor, A.K. Klemmensen, and S.F. Olsen Validity of preeclampsia-related diagnoses recorded in a national hospital registry and in a postpartum interview of the women Am J Epidemiol 166 2007 117 124 (Pubitemid 47227297)
16. M. van Eijsden, M.F. van der Wal, G. Hornstra, G.J. Bonsel, M. van Eijsden, and M.F. van der Wal Can whole-blood samples be stored over 24 hours without compromising stability of C-reactive protein, retinol, ferritin, folic acid, and fatty acids in epidemiologic research? Clin Chem 51 2005 230 232 (Pubitemid 40024042)
17. S.N. Wood Generalized additive models: an introduction with R 2006 CRC Press Chapman & Hall/Boca Raton, FL
18. S. Rana, S.A. Karumanchi, R.J. Levine, S. Venkatesha, J.A. Rauh-Hain, and H. Tamez Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia [see comment] Hypertension 50 2007 137 142 (Pubitemid 46986022)
19. Y.N. Su, C.N. Lee, W.F. Cheng, W.Y. Shau, S.N. Chow, and F.J. Hsieh Decreased maternal serum placenta growth factor in early second trimester and preeclampsia Obstet Gynecol 97 2001 898 904 (Pubitemid 32522485)
20. J.P. Kusanovic, R. Romero, T. Chaiworapongsa, O. Erez, P. Mittal, and E. Vaisbuch A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia J Matern Fetal Neonatal Med 22 2009 1021 1038
21. R.N. Taylor, J. Grimwood, R.S. Taylor, M.T. McMaster, S.J. Fisher, and R.A. North Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies Am J Obstet Gynecol 188 2003 177 182 (Pubitemid 36135616)
22. M.L. Tjoa, J.M. van Vugt, M.A. Mulders, R.B. Schutgens, C.B. Oudejans, and I.J. van Wijk Plasma placenta growth factor levels in midtrimester pregnancies [see comment] Obstet Gynecol 98 2001 600 607 (Pubitemid 32907454)
23. S.C. Tidwell, H.N. Ho, W.H. Chiu, R.J. Torry, D.S. Torry, and S.C. Tidwell Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia Am J Obstet Gynecol 184 2001 1267 1272 (Pubitemid 32434285)
24. E.R. Unal, C.J. Robinson, D.D. Johnson, and E.Y. Chang Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia Am J Obstet Gynecol 197 2007 211
25. R. Thadhani, W.P. Mutter, M. Wolf, R.J. Levine, R.N. Taylor, and V.P. Sukhatme First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia J Clin Endocrinol Metab 89 2004 770 775 (Pubitemid 38269892)
26. N. Sattar, and I.A. Greer Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 325 2002 157 160 (Pubitemid 34800133)
27. A. Montes, C.E. Walden, R.H. Knopp, M. Cheung, M.B. Chapman, and J.J. Albers Physiologic and supraphysiologic increases in lipoprotein lipids and apoproteins in late pregnancy and postpartum. Possible markers for the diagnosis of "prelipemia" Arteriosclerosis 4 1984 407 417 (Pubitemid 14092685)
28. R. Kaaja, H. Laivuori, M. Laakso, M.J. Tikkanen, O. Ylikorkala, and R. Kaaja Evidence of a state of increased insulin resistance in preeclampsia Metab Clin Exp 48 1999 892 896 (Pubitemid 29310046)
29. A.E. Barden, L.J. Beilin, J. Ritchie, B.N. Walters, C. Michael, and A.E. Barden Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia? J Hypertension 17 1999 1307 1315 (Pubitemid 29509510)
30. R.B. Ness, and R.W. Powers Epidemiology of hypertension 1999 Appleton & Lange Stanford
31. B. Eskenazi, L. Fenster, and S. Sidney A multivariate analysis of risk factors for preeclampsia JAMA 266 1991 237 241
32. E. Rey, A. Couturier, E. Rey, and A. Couturier The prognosis of pregnancy in women with chronic hypertension Am J Obstet Gynecol 171 1994 410 416 (Pubitemid 24279226)
33. R.B. Ness, N. Markovic, D. Bass, G. Harger, J.M. Roberts, and R.B. Ness Family history of hypertension, heart disease, and stroke among women who develop hypertension in pregnancy Obstet Gynecol 102 2003 1366 1371 (Pubitemid 37518420)
34. C.L. Haggerty, R.E. Ferrell, C.A. Hubel, N. Markovic, G. Harger, and R.B. Ness Association between allelic variants in cytokine genes and preeclampsia Am J Obstet Gynecol 193 2005 209 215 (Pubitemid 40991847)